Crispr Therapeutics shares owned by Frontier Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Frontier Capital Management
from 13F filings
Historical chart of Frontier Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Frontier Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Frontier Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $12M | 265k | 45.39 |
| 2023-06-30 | $21M | 376k | 56.14 |
| 2023-03-31 | $2.1M | 46k | 45.23 |
| 2022-12-31 | $2.3M | 56k | 40.65 |
| 2022-09-30 | $21M | 319k | 65.35 |
| 2022-06-30 | $10M | 169k | 60.77 |
| 2022-03-31 | $9.3M | 148k | 62.77 |
| 2020-12-31 | $488k | 3.2k | 153.17 |
| 2020-09-30 | $267k | 3.2k | 83.78 |
| 2020-06-30 | $12M | 160k | 73.49 |
| 2020-03-31 | $4.9M | 115k | 42.41 |
| 2019-12-31 | $4.7M | 77k | 60.91 |
| 2018-06-30 | $3.2M | 55k | 58.76 |
More positions owned by Frontier Capital Management
View all positions for Frontier Capital Management